Clinical Trial Update: Study in Infants (6-12 Months) Comparing Two Doses of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Vaccine Versus a Tetanus Toxoid-Conjugated Vaccine Available for the Prevention of Haemophilus Influenzae Type b Infections in China [Phase 3]

View source ↗

Summary

Phase 3 clinical trial in infants in China compared two Haemophilus influenzae type b vaccines (monovalent CRM197-conjugated vs tetanus toxoid-conjugated) for H…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilus Influenzae Type Infection

Drugs mentioned

• Hib-CRM197 conjugate vaccine (monovalent) (Haemophilus influenzae type b conjugate vaccine using diphtheria toxin CRM197)
• Tetanus toxoid-conjugated Hib vaccine (Haemophilus influenzae type b conjugate vaccine using tetanus toxoid)

Snippet

Sponsor: Novartis Vaccines | Conditions: Haemophilus Influenzae Type b (Hib) Infection | Phase 3 | Status: COMPLETED